ZRFY yields 2000000.00% · ABBV yields 3.06%● Live data
📍 ZRFY pulled ahead of the other in Year 1
Combined, ZRFY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZRFY + ABBV for your $10,000?
Zerify, Inc. provides software development and services worldwide. The company develops and licenses various identification protection software products to protect computer networks from unauthorized access, as well as to protect network owners and users from cyber security attacks and data breaches. It offers ProtectID, an authentication platform to authenticate computer network users by various methods, including traditional passwords combined with a telephone, iPhone, Droid, Blackberry, PDA, multiple computer secure sessions, biometric identification, and encrypted devices, as well as through a push authentication method; and GuardedID that prevents the use of spyware/malware to collect user information. The company's products also comprise MobileTrust, an iPhone/iPad and Android device password vault that includes a password generator, as well as provides for mobile multi-factor one time password authentication; GuardedID mobile software development kit; SafeVchat video conferencing product; and PrivacyLok, which offers protective mechanisms. In addition, it provides software and hardware that are contractually licensed from other vendors, as well as additional authentication and telecommunication software devices. The company markets its products to financial service firms; healthcare related, legal services, virtual private network, technology service, and e-commerce companies; automotive; government agencies; multi-level marketing groups; and retail distributors, as well as the enterprise market. It sells its products directly to consumers through internet, distributors, resellers, third party agents, affiliates, and original equipment manufacturer agreements. The company was formerly known as StrikeForce Technologies, Inc. and changed its name to Zerify, Inc. in June 2022. Zerify, Inc. was incorporated in 2001 and is headquartered in Edison, New Jersey.
Full ZRFY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.